Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread haemophagocytosis and cytokine overproduction. It is seen most commonly in systemic juvenile idiopathic arthritis, but is increasingly recognized also in juvenile systemic lupus erythematosus (J-SLE). Recognition of MAS in patients with J-SLE is often challenging because it may mimic the clinical features of the underlying disease or be confused with an infectious complication. This review summarizes the characteristics of patients with J-SLE-associated MAS reported in the literature or seen by the authors and analyses the distinctive clinical, diagnostic and therapeutic issues that the occurrence of MAS may raise in patients with J-SLE.

Pringe, A., Trail, L., Ruperto, N., Buoncompagni, A., Loy, A., Breda, L., et al. (2007). Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?. LUPUS, 16(8), 587-592 [10.1177/0961203307079078].

Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?

Ruperto N;
2007

Abstract

Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread haemophagocytosis and cytokine overproduction. It is seen most commonly in systemic juvenile idiopathic arthritis, but is increasingly recognized also in juvenile systemic lupus erythematosus (J-SLE). Recognition of MAS in patients with J-SLE is often challenging because it may mimic the clinical features of the underlying disease or be confused with an infectious complication. This review summarizes the characteristics of patients with J-SLE-associated MAS reported in the literature or seen by the authors and analyses the distinctive clinical, diagnostic and therapeutic issues that the occurrence of MAS may raise in patients with J-SLE.
Articolo in rivista - Articolo scientifico
Childhood; Juvenile-onset systemic lupus erythematosus; Macrophage activations syndrome; Paediatrics; Reactive haemophagocytic syndrome;
English
2007
16
8
587
592
reserved
Pringe, A., Trail, L., Ruperto, N., Buoncompagni, A., Loy, A., Breda, L., et al. (2007). Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?. LUPUS, 16(8), 587-592 [10.1177/0961203307079078].
File in questo prodotto:
File Dimensione Formato  
Pringe-2007-Lupus-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 188.39 kB
Formato Adobe PDF
188.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/558022
Citazioni
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 53
Social impact